Objectives: To evaluate the effect of Vitamin D supplementation on proteinuria in type 2 Diabetes Mellitus patients in Chinese population. Materials and Methods: The design of this study was Quasi-experimental study design and the duration of this study was from December 2021 to June 2022. This study was conducted in the Department of medicine, in DHQ Hospital Faisalabad. Totally 30 patients who were suffering from type 2 diabetic mellitus disease were enrolled. Vitamin D levels Proteinuria, HbA1c and FBS level was evaluated. Oral Vitamin D 50,000 IU weekly dose was given to Patients with Vit D deficiency for 8 weeks. At the end of 8 week the Vitamin D levels, FBS, HbA1c and Albumin level was evaluated again. All the demographic details and study results were recorded on a predesigned data collection proforma. Results: Out of total 30 patients, 11 were male and 19 were female with mean age of 34.73±9.14 years. The most common age group was 41-50 years in which 36.7%, followed by age group of 31-40 years in which 33.3% and 30.0% patients were in age group of 41-50 years. The statistical difference between Pre-intervention and post-intervention was calculated, and p-value was significant. In our study the Vit D level increases while proteinuria decreases. Practical Implication: In diabetic patients its deficiency lead to a number of serious condition such as ischemic heart disease, CKD and Diabetic nephropathy. Vit D play its role in the inhibition of the renin-angiotensin system. It also have a protective role in the renal by preventing of glomerulosclerosis and anti-proteinuric effect. Conclusion: Vitamin D supplementation is helpful in increasing Vit D level in T2DM patients. And also helpful in decreasing proteinuria. This means that correction of Vit D level can decrease proteinuria. Keywords: Vitamin D, Proteinuria, Type 2 Diabetes Mellitus, Albumin Level, Proteinuria, Threatening Disorder.
Background: Infertility is defined as the inability to conceive after one to two years of unprotected intercourse. It is of two types: primary infertility and secondary infertility 5On the basis of etiopathology infertility is divided into five groups: unexplained (28%), male factor (24%), ovarian dysfunction (21%), tubal factor (14%) and others (13%). Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are integral parts of the neural and endocrine interchange between the hypothalamus, pituitary, and gonads that control steroid hormone synthesis and gamete production. Method: The design of this study was a Cross sectional study design. The study was conducted in Shifa International Hospital Islamabad and the duration of this study were from May 2022 to Nov 2022 for the duration of six months. Results: A total of 143 female patients presenting with an ovulatory cycle with primary infertility. Average age of the patients was 29.14 years +5.65 SD with range 20-38 years. The deranged follicle stimulating hormone and deranged luteinizing hormone in IU/L among women presenting with an ovulatory cycle with primary infertility was observed in 85(59.44%) and 56(39.16%) respectively. Practical implication: This study will be useful to local health professionals in adjusting the management protocols for patients with primary infertility Conclusion: The deranged follicle stimulating hormone and deranged luteinizing hormone in IU/L are the considerable factors among women presenting with an ovulatory cycle with primary infertility Keywords: Follicle Stimulating Hormone, Luteinizing Hormone, An Ovulatory Cycle, Primary Infertility
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.